panel shares thoughts on luspatercept for mds and future research needs for this therapy
Published 10 months ago • 34 plays • Length 6:55Download video MP4
Download video MP3
Similar videos
-
7:14
phase iii medalist trial of luspatercept for mds
-
0:56
the promise of luspatercept for the treatment of lower-risk mds
-
4:21
evaluating luspatercept in combination with esas for the treatment of anemia in lr-mds
-
8:02
what to know about optimal luspatercept use in lower-risk mds
-
2:26
ace-536-mf-001 update: luspatercept for the treatment of anemia in myelofibrosis
-
6:32
luspatercept reduces transfusion burden in mds-related anemia: medalist results
-
4:36
commands: luspatercept versus epoetin alfa in lr-mds-associated anemia - results & caveats
-
1:28
bill: what have been the greatest successes and challenges with your mds-related anemia treatment?
-
5:20
real-world outcomes of non-transfusion-dependent patients with mds treated with luspatercept
-
3:12
guillermo garcia-manero, md, shares latest luspatercept findings for mds, anemia
-
0:56
luspatercept for mds-associated anemia
-
2:12
improving the treatment of low-risk mds: luspatercept, treatment sequencing & disease classification
-
5:30
commands: luspatercept vs epoetin alfa for anemia in esa-naive lr-mds
-
14:41
luspatercept compared with other available therapies for mf
-
2:07:09
mpn clinical trial updates for patients
-
5:26
nct03194542 trial: luspatercept for the treatment of patients with anemic myelofibrosis
-
5:28
new therapies for transfusion dependent mds patients
-
5:42
aziz nazha: a personalized prediction model for mds
-
5:26
real-world outcomes of non-transfusion-dependent patients with mds treated with luspatercept